Keywords: Merger and acquisition activity, 2010, Pharma, Biotech, Generics

Pharma and biotech M&A activity in 2010 up in numbers, but no mega deals that year

Article | 13 January 2011

With many drug majors facing patent expiries on blockbuster drugs, the year 2010 was marked by a plethora of licensing deals ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in